Quince Therapeutics
QNCX
QNCX
52 hedge funds and large institutions have $594M invested in Quince Therapeutics in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+11
Holders Change %
+26.83%
% of All Funds
1.03%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
16
Increased
26
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
$32.9M |
| 2 |
Capital World Investors
Los Angeles,
California
|
$32.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$23.1M |
| 4 |
State Street
Boston,
Massachusetts
|
$9.88M |
| 5 |
MWNA
Marshall Wace North America
New York
|
$5.81M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ASN
51
Advisory Services Network
Atlanta,
Georgia
| $1K | +$1K | +25 | New |
|
|
EC
52
EcoR1 Capital
San Francisco,
California
| – | -$1.25M | -49,993 | Closed |
|
53
Millennium Management
New York
| – | -$529K | -21,239 | Closed |
|
54
Victory Capital Management
San Antonio,
Texas
| – | -$20K | -796 | Closed |
|
55
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$2K | -95 | Closed |
|
56
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -67 | Closed |
|